The Quantellect read.As of Nov 19, 2026, 3 active firms cover Compugen: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $4.00 to $6.00, a moderate spread. The average target of $5.00 sits 154% above the current $1.97. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.35 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$5.00
+154.5% upside
Average target across 3 active firms as of Nov 19, 2026 vs $1.97 current
Highest Target$6.00
Average Target$5.00
Lowest Target$4.00
Detailed analyst forecasts for CGEN
Showing 1–2 of 2 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate CGEN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CGEN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.07 – $-0.07 · 1 analysts · -12% YoY
Next period, 1 analysts expect Compugen to earn $-0.07 a share (range $-0.07 – $-0.07), versus $-0.08 a year earlier. Full-year consensus is $-0.30, growing to $-0.35 the year after.
REVENUE · NEXT QUARTER
$700.0K
Range $0 – $1.4M · 1 analysts · -68% YoY
Revenue is expected to reach $700.0K (range $0 – $1.4M), -67.8% year-over-year. Full-year consensus is $12.1M, rising to $7.7M next year.
Top analysts covering Compugen
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CGEN.
#1
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$4.00+103.6% to target
Overall win rate
38%
+ Follow
#2
Daina Graybosch
Leerink Partners · Rank #396
Buy
$5.00+154.5% to target
Overall win rate
41%
+ Follow
#3
Leland Gershell
Oppenheimer · Rank #404
Buy
$4.00+103.6% to target
Overall win rate
35%
+ Follow
#4
CM
Chad Messer
Lake Street
Buy
$6.00+205.3% to target
Coverage
—
+ Follow
#5
Asthika Goonewardene
Truist Securities
Buy
$4.00+103.6% to target
Coverage
—
+ Follow
CGEN stock forecast FAQ
What is CGEN's average 12-month price target?+
The 3 active firms with a live target average $5.00 for Compugen over the next 12 months, ranging from a $6.00 high to a $4.00 low, as of Nov 19, 2026.
Is CGEN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CGEN?+
The Street-high target is $6.00 (Lake Street), and the Street-low is $4.00 (HC Wainwright & Co.). The average of all 3 active-firm targets is $5.00.
How many active Wall Street firms cover CGEN?+
3 active firms have a recognized rating on Compugen as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CGEN?+
Among analysts who currently cover CGEN, Swayampakula Ramakanth of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #321). Their current call is Buy with a $4.00 target.
What is Compugen's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.07 – $-0.07) across 1 analysts. Full-year EPS is projected at $-0.30, rising to $-0.35 the following year.
How much revenue is Compugen expected to report next quarter?+
Consensus revenue is $700.0K (range $0 – $1.4M). Full-year revenue is projected at $12.1M, growing to $7.7M next year.
Have analysts been upgrading or downgrading CGEN lately?+
As of Nov 19, 2026, 3 of 3 active firms rate CGEN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.